ENANTA PHARMACEUTICALS, INC Tax Withholding Paid on Stock Awards
ENANTA PHARMACEUTICALS, INC (ENTA) reported Tax Withholding Paid on Stock Awards of $402.00 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $305.00K, a 140.16% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $97.00K, a 29.20% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $10.00K, a 47.37% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC payment, tax withholding, share-based payment arrangement for fiscal 2025 was $277.00K, a 5.78% decline from fiscal 2024.
- ENANTA PHARMACEUTICALS, INC payment, tax withholding, share-based payment arrangement for fiscal 2024 was $294.00K, a 92.17% decline from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC payment, tax withholding, share-based payment arrangement for fiscal 2023 was $3.76M, a 205.70% increase from fiscal 2022.
- ENANTA PHARMACEUTICALS, INC payment, tax withholding, share-based payment arrangement for fiscal 2022 was $1.23M, a 130.15% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $305.00K derived: sum of 2 quarters · filed 2026-08-12 | $402.00K 10-Q · filed 2026-08-12 | $412.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $305.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $402.00K 10-Q · filed 2026-05-13 | $412.00K derived: sum of 3 quarters · filed 2026-05-13 | $415.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $97.00K 10-Q · filed 2026-02-11 | $107.00K derived: sum of 2 quarters · filed 2026-02-11 | $110.00K derived: sum of 3 quarters · filed 2026-08-12 | $237.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-09-30 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $13.00K derived: sum of 2 quarters · filed 2026-08-12 | $140.00K derived: sum of 3 quarters · filed 2026-08-12 | $277.00K 10-K · filed 2025-11-19 |
| 2025-06-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $130.00K derived: sum of 2 quarters · filed 2026-08-12 | $267.00K 10-Q · filed 2026-08-12 | $286.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $264.00K 10-Q · filed 2026-05-13 | $283.00K derived: sum of 3 quarters · filed 2026-05-13 | $283.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $137.00K 10-Q · filed 2026-02-11 | $156.00K derived: sum of 2 quarters · filed 2026-02-11 | $156.00K derived: sum of 3 quarters · filed 2026-02-11 | $248.00K derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $19.00K derived: sum of 2 quarters · filed 2025-11-19 | $111.00K derived: sum of 3 quarters · filed 2025-11-19 | $294.00K 10-K · filed 2025-11-19 |
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | $92.00K derived: sum of 2 quarters · filed 2025-08-13 | $275.00K 10-Q · filed 2025-08-13 | $298.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-03-31 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $275.00K 10-Q · filed 2025-05-14 | $298.00K derived: sum of 3 quarters · filed 2025-11-19 | $298.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-12-31 | $183.00K 10-Q · filed 2025-02-12 | $206.00K derived: sum of 2 quarters · filed 2025-11-19 | $206.00K derived: sum of 3 quarters · filed 2025-11-19 | $3.12M derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-09-30 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $23.00K derived: sum of 2 quarters · filed 2025-11-19 | $2.93M derived: sum of 3 quarters · filed 2025-11-19 | $3.76M 10-K · filed 2025-11-19 |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07 | $2.91M derived: sum of 2 quarters · filed 2024-08-07 | $3.73M 10-Q · filed 2024-08-07 | $3.73M derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | $2.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | $3.73M 10-Q · filed 2024-05-08 | $3.73M derived: sum of 3 quarters · filed 2024-11-27 | $3.73M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-12-31 | $825.00K 10-Q · filed 2024-02-08 | $826.00K derived: sum of 2 quarters · filed 2024-11-27 | $826.00K derived: sum of 3 quarters · filed 2024-11-27 | $1.28M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-09-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $1.00K derived: sum of 2 quarters · filed 2024-11-27 | $452.00K derived: sum of 3 quarters · filed 2024-11-27 | $1.23M 10-K · filed 2024-11-27 |
| 2022-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $451.00K derived: sum of 2 quarters · filed 2023-08-08 | $1.23M 10-Q · filed 2023-08-08 | $1.23M derived: sum of 4 quarters · filed 2023-11-22 |
| 2022-03-31 | $451.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09 | $1.23M 10-Q · filed 2023-05-09 | $1.23M derived: sum of 3 quarters · filed 2023-11-22 | $1.23M derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-12-31 | $777.00K 10-Q · filed 2023-02-08 | $777.00K derived: sum of 2 quarters · filed 2023-11-22 | $777.00K derived: sum of 3 quarters · filed 2023-11-22 | $777.00K derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22 | $0.00 derived: sum of 2 quarters · filed 2023-11-22 | $0.00 derived: sum of 3 quarters · filed 2023-11-22 | $534.00K 10-K · filed 2023-11-22 |
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08 | $0.00 derived: sum of 2 quarters · filed 2022-08-08 | $534.00K 10-Q · filed 2022-08-08 | $534.00K derived: sum of 4 quarters · filed 2022-11-23 |
| 2021-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09 | $534.00K 10-Q · filed 2022-05-09 | $534.00K derived: sum of 3 quarters · filed 2022-11-23 | $534.00K derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-12-31 | $534.00K 10-Q · filed 2022-02-10 | $534.00K derived: sum of 2 quarters · filed 2022-11-23 | $534.00K derived: sum of 3 quarters · filed 2022-11-23 | $892.00K derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23 | $0.00 derived: sum of 2 quarters · filed 2022-11-23 | $358.00K derived: sum of 3 quarters · filed 2022-11-23 | $1.50M 10-K · filed 2022-11-23 |
| 2020-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09 | $358.00K derived: sum of 2 quarters · filed 2021-08-09 | $1.50M 10-Q · filed 2021-08-09 | $1.50M derived: sum of 4 quarters · filed 2021-11-24 |
| 2020-03-31 | $358.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10 | $1.50M 10-Q · filed 2021-05-10 | $1.50M derived: sum of 3 quarters · filed 2021-11-24 | $1.50M derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-12-31 | $1.14M 10-Q · filed 2021-02-09 | $1.14M derived: sum of 2 quarters · filed 2021-11-24 | $1.14M derived: sum of 3 quarters · filed 2021-11-24 | |
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $0.00 derived: sum of 2 quarters · filed 2021-11-24 | $4.19M 10-K · filed 2021-11-24 | |
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10 | $4.19M 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $4.19M 10-Q · filed 2020-05-11 | |||
| 2018-09-30 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | -$1.00K derived: sum of 2 quarters · filed 2020-11-25 | $1.76M 10-K · filed 2020-11-25 | |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09 | $1.76M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $1.76M 10-Q · filed 2019-05-10 | |||
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $0.00 derived: sum of 2 quarters · filed 2019-11-27 | $202.00K 10-K · filed 2019-11-27 | |
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | $202.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $202.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |